Lorna Neill

2.8k total citations · 1 hit paper
25 papers, 946 citations indexed

About

Lorna Neill is a scholar working on Oncology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lorna Neill has authored 25 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Rheumatology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lorna Neill's work include CAR-T cell therapy research (8 papers), Vasculitis and related conditions (5 papers) and Otitis Media and Relapsing Polychondritis (4 papers). Lorna Neill is often cited by papers focused on CAR-T cell therapy research (8 papers), Vasculitis and related conditions (5 papers) and Otitis Media and Relapsing Polychondritis (4 papers). Lorna Neill collaborates with scholars based in United Kingdom, Australia and United States. Lorna Neill's co-authors include Elisabeth Brouwer, Bhaskar Dasgupta, Wolfgang Schmidt, Christian Dejaco, Thorsten Alexander Bley, Annamaria Iagnocco, Cristina Ponte, Marco A. Cimmino, Florent L. Besson and Andreas P. Diamantopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

Lorna Neill

25 papers receiving 936 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

2018 577 citations Christian Dejaco, Sofía Ramiro et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Lorna Neill

Since Specialization

Citations

This map shows the geographic impact of Lorna Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna Neill more than expected).

Fields of papers citing papers by Lorna Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna Neill. The network helps show where Lorna Neill may publish in the future.

Co-authorship network of co-authors of Lorna Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna Neill. A scholar is included among the top collaborators of Lorna Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna Neill. Lorna Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma 2024 ·HemaSphere ·Maeve O’Reilly, Lorna Neill, Simon M. Collin, Neil Stone, (unknown), (unknown), (unknown), Katarzyna Aleksandra Jalowiec, Reuben Benjamin, Andrea Kühnl, Claire Roddie, Robin Sanderson	5
2	Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma 2023 ·Blood Advances ·Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, (unknown), Maria A. V. Marzolini, William Townsend, Maeve O’Reilly, Amy A. Kirkwood, Andrea Kühnl	64
3	Test-retest reliability of pain VAS/NRS, stiffness VAS/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: An OMERACT study 2023 ·Seminars in Arthritis and Rheumatism ·(unknown), Helen Twohig, Sara Müller, Lara Maxwell, Sarah Mackie, Lorna Neill, Claire Owen	3
4	A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture 2022 ·Cytotherapy ·Maeve O’Reilly, (unknown), (unknown), Stuart J. Ings, (unknown), (unknown), Katarzyna Aleksandra Jalowiec, Lorna Neill, Karl S. Peggs, Claire Roddie	13
5	Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma 2021 ·SHILAP Revista de lepidopterología ·Maria A. V. Marzolini, Lorna Neill, Maeve O’Reilly, Karl S. Peggs, Claire Roddie	1
6	Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report 2021 ·SHILAP Revista de lepidopterología ·(unknown), Manar Shafat, (unknown), Harpreet Hyare, Lorna Neill, Maria A. V. Marzolini, Michael James Gilhooley, Teresa Marafioti, Eleanna Kara, Emilie Sanchez, Jeremy Rees, David S. Lynch, Kirsty Thomson, Kirit M. Ardeshna, Arian Laurence, Karl S. Peggs, Maeve O’Reilly, Claire Roddie	7
7	Multi-organ graft-versus-host disease after nivolumab for relapsed Hodgkin lymphoma: the role of plasma exchange 2021 ·The Lancet Haematology ·(unknown), Lorna Neill, Manar Shafat, (unknown), Harpreet Hyare, (unknown), Kirsty Thomson, Karl S. Peggs, Arian Laurence, Maeve O’Reilly, Claire Roddie	5
8	CAR-T Toxicity Management and Steroid Use in High-Grade B-Cell Lymphoma: Impact on Real-World Survival Outcomes in the UK 2021 ·Blood ·Robin Sanderson, Andrea Kühnl, Eleni Tholouli, Tobias Menne, Amit Patel, Sridhar Chaganti, Caroline Besley, Emma Nicholson, Anne‐Louise Latif, Ceri Jones, (unknown), (unknown), Amrith Mathew, (unknown), (unknown), Lorna Neill, (unknown), Katarzyna Aleksandra Jalowiec, Claire Roddie, Maeve O’Reilly	6
9	Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study 2020 ·The Journal of Rheumatology ·Max Yates, Claire Owen, Sara Müller, (unknown), Lorna Neill, Helen Twohig, Maarten Boers, Mar Pujades‐Rodríguez, Susan M. Goodman, Jonathan T. L. Cheah, Christian Dejaco, Chetan Mukhtyar, Berit Dalsgaard Nielsen, Joanna Robson, (unknown), Beverley Shea, Sarah Mackie, Catherine Hill	7
10	Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective 2020 ·The Lancet Rheumatology ·Sarah Mackie, Elisabeth Brouwer, Richard Conway, Kornelis S. M. van der Geest, Puja Mehta, Susan P. Mollan, Lorna Neill, Michael Putman, Philip C. Robinson, Sebastian E. Sattui	19
11	Steroid Use, Advanced Stage Disease and ≥3 Lines of Prior Chemotherapy Are Associated with a Higher Risk of Infection Following CD19 CAR T-Cell Therapy for B-NHL: Real World Data from a Large UK Center 2020 ·Blood ·Lorna Neill, (unknown), Maria A. V. Marzolini, William Townsend, Kirit M. Ardeshna, Kate Cwynarski, (unknown), Vanya Gant, (unknown), (unknown), (unknown), Karl S. Peggs, Claire Roddie, Maeve O’Reilly	8
12	2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 2019 ·Annals of the Rheumatic Diseases ·Lisa Ehlers, Johan Askling, (unknown), (unknown), Maurizio Cutolo, Bhaskar Dasgupta, Christian Dejaco, William G Dixon, Nils Feltelius, Axel Finckh, Kate Gilbert, Sarah Mackie, Alfred Mahr, Eric L. Matteson, Lorna Neill, Carlo Salvarani, Wolfgang Schmidt, Anja Strangfeld, Ronald van Vollenhoven, Frank Buttgereit	57
13	Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group 2019 ·The Journal of Rheumatology ·Claire Owen, Max Yates, Helen Twohig, Sara Müller, Lorna Neill, (unknown), Beverley Shea, (unknown), Catherine Hill, Sarah Mackie	6
14	Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess 2019 ·BMC Infectious Diseases ·Lorna Neill, (unknown), Simon M. Collin, David Harrington, (unknown), G. Gopal Rao, Alastair McGregor	23
15	EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice breakdown → 2018 ·Annals of the Rheumatic Diseases ·Christian Dejaco, Sofía Ramiro, Christina Duftner, Florent L. Besson, Thorsten Alexander Bley, Daniël Blockmans, Elisabeth Brouwer, Marco A. Cimmino, Eric Clark, Bhaskar Dasgupta, Andreas P. Diamantopoulos, Haner Di̇reskeneli̇, Annamaria Iagnocco, Thorsten Klink, Lorna Neill, Cristina Ponte, Carlo Salvarani, Riemer H. J. A. Slart, Madeline Whitlock, Wolfgang Schmidt	577
16	O28 Experience of female genital mutilation (FGM) in a sexual health clinic 2017 ·Sexually Transmitted Infections ·Lorna Neill, (unknown), Siobhán Murphy, John McSorley, Gary Brook	1
17	The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica 2017 ·The Journal of Rheumatology ·Sarah Mackie, Helen Twohig, Lorna Neill, (unknown), Beverley Shea, Rachel Black, Tanaz A. Kermani, Peter A. Merkel, Christian Mallen, Frank Buttgereit, Chetan Mukhtyar, Lee S. Simon, Catherine Hill, (unknown)	35
18	A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group 2017 ·The Journal of Rheumatology ·Rachel Black, Joanna Robson, Susan M. Goodman, Elizabeth Hoon, Lana Yin Hui Lai, Lee S. Simon, (unknown), Lorna Neill, P. Scott Richards, Linda Nelsen, (unknown), Sarah Mackie, Catherine Hill	17
19	Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group 2016 ·The Journal of Rheumatology ·Serena Halls, (unknown), Sarah Hewlett, Sarah Mackie, Lyn March, Susan J. Bartlett, Clifton O. Bingham, Rieke Alten, (unknown), Catherine Hill, Robert J. Holt, Rod Hughes, John Kirwan, Amye Leong, Ying Ying Leung, Anne Lyddiatt, Lorna Neill, Ana‐Maria Orbai	13
20	Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group 2015 ·The Journal of Rheumatology ·Toby Helliwell, Elisabeth Brouwer, Colin Pease, Rodney Hughes, Catherine Hill, Lorna Neill, Serena Halls, (unknown), Christian Mallen, Maarten Boers, John Kirwan, Sarah Mackie	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact